Hydroxychloroquine prophylaxis for COVID-19 contacts in India
Item
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Title
Hydroxychloroquine prophylaxis for COVID-19 contacts in India
Subject
Description
More than a billion Indians currently stand at the precipice of a massive increase in cases of coronavirus disease 2019 (COVID-19). India had shown a staggered course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission, with 1397 cases diagnosed between Jan 31, and April 1, 2020. However, there has been a recent surge in cases, with numbers rising to 5194 as of April 8
Responses to this article was published:
Responses to this article was published:
- Tilangi, Praveen, Devashish Desai, Adil Khan, and Manish Soneja. 2020. "Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach." The Lancet Infectious Diseases.
- Afra, T. P., Muhammed Razmi T, Anuradha Bishnoi, and N. A. Bishurul Hafi. 2020. "Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?" The Lancet Infectious Diseases.
Date
2020-04-17
Type
Citation
Rathi, Sahaj, Pranav Ish, Ashwini Kalantri, and Shriprakash Kalantri. 2020. "Hydroxychloroquine prophylaxis for COVID-19 contacts in India." The Lancet Infectious Diseases.
Accessibility
Free online on Lancet site.
Was this resource helpful?